CD8+ T cell-derived IFN-γ prevents infection by a second heterologous virus

Journal of Immunology

Volumn 189, Issue 12, 2012, Pages 5841-5848

  Valentine, Laura ^a   Potts, Rashaun ^b   Premenko Lanier, Mary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INFECTION PREVENTION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MIXED INFECTION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA; VACCINIA VIRUS; VIRAL CLEARANCE; VIRUS IDENTIFICATION; VIRUS INFECTION;

ACUTE DISEASE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; FEMALE; HELA CELLS; HUMANS; INTERFERON-GAMMA; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; VACCINIA; VACCINIA VIRUS;

EID: 84871118297     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201679     Document Type: Article

References (56)

1. Golden-Mason, L., B. Palmer, J. Klarquist, J. A. Mengshol, N. Castelblanco, and H. R. Rosen. 2007. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J. Virol. 81: 9249-9258. (Pubitemid 47311467)
2. Gruener, N. H., F. Lechner, M. C. Jung, H. Diepolder, T. Gerlach, G. Lauer, B. Walker, J. Sullivan, R. Phillips, G. R. Pape, and P. Klenerman. 2001. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 75: 5550-5558. (Pubitemid 32488148)
3. Wedemeyer, H., X. S. He, M. Nascimbeni, A. R. Davis, H. B. Greenberg, J. H. Hoofnagle, T. J. Liang, H. Alter, and B. Rehermann. 2002. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169: 3447-3458. (Pubitemid 35013196)
4. van Grevenynghe, J., R. A. Cubas, S. Dafonseca, T. Metcalf, C. L. Tremblay, L. Trautmann, R. P. Sekaly, J. Schatzle, and E. K. Haddad. 2012. Foxo3a: An integrator of immune dysfunction during HIV infection. Cytokine Growth Factor Rev. 23: 215-221.
5. Nixon, D. E., and A. L. Landay. 2010. Biomarkers of immune dysfunction in HIV. Curr. Opin. HIV AIDS 5: 498-503.
6. Epeldegui, M., E. Vendrame, and O. Martínez-Maza. 2010. HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma. Immunol. Res. 48: 72-83.
7. Kottilil, S., K. Shin, J. O. Jackson, K. N. Reitano, M. A. O'Shea, J. Yang, C. W. Hallahan, R. Lempicki, J. Arthos, and A. S. Fauci. 2006. Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions. J. Immunol. 176: 1107-1114. (Pubitemid 43099712)
8. Westby, M., J. B. Marriott, M. Guckian, S. Cookson, P. Hay, and A. G. Dalgleish. 1998. Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-assocated markers of immune dysfunction. Clin. Exp. Immunol. 111: 257-263. (Pubitemid 28088304)
9. Mueller, S. N., and R. Ahmed. 2009. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. USA 106: 8623-8628.
10. Sarkar, S., V. Kalia, W. N. Haining, B. T. Konieczny, S. Subramaniam, and R. Ahmed. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205: 625-640. (Pubitemid 351439309)
11. Wherry, E. J., V. Teichgräber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234. (Pubitemid 36322131)
12. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927. (Pubitemid 36402840)
13. Ahmed, R., A. Salmi, L. D. Butler, J. M. Chiller, and M. B. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160: 521-540. (Pubitemid 14052514)
14. Zuniga, E. I., L. Y. Liou, L. Mack, M. Mendoza, and M. B. Oldstone. 2008. Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections. Cell Host Microbe 4: 374-386.
15. Brooks, D. G., L. Teyton, M. B. Oldstone, and D. B. McGavern. 2005. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79: 10514-10527. (Pubitemid 41098591)
16. Sevilla, N., D. B. McGavern, C. Teng, S. Kunz, and M. B. Oldstone. 2004. Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J. Clin. Invest. 113: 737-745. (Pubitemid 38544167)
17. Naniche, D., and M. B. Oldstone. 2000. Generalized immunosuppression: how viruses undermine the immune response. Cell. Mol. Life Sci. 57: 1399-1407.
18. Tishon, A., H. Lewicki, G. Rall, M. Von Herrath, and M. B. Oldstone. 1995. An essential role for type 1 interferon-gamma in terminating persistent viral infection. Virology 212: 244-250.
19. Althage, A., B. Odermatt, D. Moskophidis, T. Kündig, U. Hoffman-Rohrer, H. Hengartner, and R. M. Zinkernagel. 1992. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Eur. J. Immunol. 22: 1803-1812.
20. Borrow, P., C. F. Evans, and M. B. Oldstone. 1995. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69: 1059-1070.
21. Roost, H., S. Charan, R. Gobet, E. Rüedi, H. Hengartner, A. Althage, and R. M. Zinkernagel. 1988. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus. Eur. J. Immunol. 18: 511-518.
22. Brenan, M., and R. M. Zinkernagel. 1983. Influence of one virus infection on a second concurrent primary in vivo antiviral cytotoxic T-cell response. Infect. Immun. 41: 470-475. (Pubitemid 13075224)
23. Shin, H., and E. J. Wherry. 2007. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19: 408-415. (Pubitemid 47284857)
24. Intlekofer, A. M., N. Takemoto, C. Kao, A. Banerjee, F. Schambach, J. K. Northrop, H. Shen, E. J. Wherry, and S. L. Reiner. 2007. Requirement for Tbet in the aberrant differentiation of unhelped memory CD8+ T cells. J. Exp. Med. 204: 2015-2021. (Pubitemid 47360863)
25. Blackburn, S. D., and E. J. Wherry. 2007. IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 15: 143-146. (Pubitemid 46528253)
26. Oldstone, M. B. 2007. A suspenseful game of 'hide and seek' between virus and host. Nat. Immunol. 8: 325-327. (Pubitemid 46745403)
27. Lee, L. N., S. Burke, M. Montoya, and P. Borrow. 2009. Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice. J. Immunol. 182: 7178-7189.
28. Mack, E. A., L. E. Kallal, D. A. Demers, and C. A. Biron. 2011. Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection. MBio. 2: e00169-11.
29. Nagata, S., N. Mantei, and C. Weissmann. 1980. The structure of one of the eight or more distinct chromosomal genes for human interferon-alpha. Nature 287: 401-408. (Pubitemid 11250346)
30. Mogensen, K. E., G. Uzé, and P. Eid. 1989. The cellular receptor of the alphabeta interferons. Experientia 45: 500-508.
31. Müller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921. (Pubitemid 24245635)
32. González-Navajas, J. M., J. Lee, M. David, and E. Raz. 2012. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12: 125-135.
33. Welsh, R. M., K. Bahl, H. D. Marshall, and S. L. Urban. 2012. Type 1 interferons and antiviral CD8 T-cell responses. PLoS Pathog. 8: e1002352.
34. Kulesh, D. A., R. O. Baker, B. M. Loveless, D. Norwood, S. H. Zwiers, E. Mucker, C. Hartmann, R. Herrera, D. Miller, D. Christensen, et al. 2004. Smallpox and pan-orthopox virus detection by real-time 3′-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms. J. Clin. Microbiol. 42: 601-609. (Pubitemid 38222635)
35. Sheehan, K. C., K. S. Lai, G. P. Dunn, A. T. Bruce, M. S. Diamond, J. D. Heutel, C. Dungo-Arthur, J. A. Carrero, J. M. White, P. J. Hertzog, and R. D. Schreiber. 2006. Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 26: 804-819. (Pubitemid 44764543)
36. Cembrzyńska-Nowak, M. 1989. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C. Arch. Immunol. Ther. Exp. (Warsz.) 37: 499-502. (Pubitemid 20365330)
37. Esteban, M., J. Benavente, and E. Paez. 1986. Mode of sensitivity and resistance of vaccinia virus replication to interferon. J. Gen. Virol. 67: 801-808. (Pubitemid 16048062)
38. Rodriguez, J. R., D. Rodriguez, and M. Esteban. 1991. Interferon treatment inhibits early events in vaccinia virus gene expression in infected mice. Virology 185: 929-933.
39. Stamm, A., L. Valentine, R. Potts, and M. Premenko-Lanier. 2012. An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells. Virology 425: 122-132.
40. Biron, C. A. 1998. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10: 383-390. (Pubitemid 28499552)
41. Schoenborn, J. R., and C. B. Wilson. 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 96: 41-101. (Pubitemid 350018717)
42. Shen, Z. T., M. A. Brehm, K. A. Daniels, A. B. Sigalov, L. K. Selin, R. M. Welsh, and L. J. Stern. 2010. Bi-specific MHC heterodimers for characterization of cross-reactive T cells. J. Biol. Chem. 285: 33144-33153.
43. Leist, T. P., M. Eppler, and R. M. Zinkernagel. 1989. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice. J. Virol. 63: 2813-2819. (Pubitemid 19137561)
44. Sullivan, B. M., S. F. Emonet, M. J.Welch, A. M. Lee, K. P. Campbell, J. C. de la Torre, and M. B. Oldstone. 2011. Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Proc. Natl. Acad. Sci. USA 108: 2969-2974.
45. Perdiguero, B., and M. Esteban. 2009. The interferon system and vaccinia virus evasion mechanisms. J. Interferon Cytokine Res. 29: 581-598.
46. Bogdan, C., J. Mattner, and U. Schleicher. 2004. The role of type I interferons in non-viral infections. Immunol. Rev. 202: 33-48. (Pubitemid 39576903)
47. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5: 1249-1255. (Pubitemid 29535601)
48. Ito, T., R. Amakawa, M. Inaba, S. Ikehara, K. Inaba, and S. Fukuhara. 2001. Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166: 2961-2969. (Pubitemid 33117291)
49. Le Bon, A., N. Etchart, C. Rossmann, M. Ashton, S. Hou, D. Gewert, P. Borrow, and D. F. Tough. 2003. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4: 1009-1015. (Pubitemid 37265922)
50. Le Bon, A., G. Schiavoni, G. D'Agostino, I. Gresser, F. Belardelli, and D. F. Tough. 2001. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14: 461-470. (Pubitemid 32441598)
51. Montoya, M., G. Schiavoni, F. Mattei, I. Gresser, F. Belardelli, P. Borrow, and D. F. Tough. 2002. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99: 3263-3271. (Pubitemid 34525306)
52. Trinchieri, G., and D. Santoli. 1978. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J. Exp. Med. 147: 1314-1333. (Pubitemid 8328674)
53. Hervas-Stubbs, S., J. L. Perez-Gracia, A. Rouzaut, M. F. Sanmamed, A. Le Bon, and I. Melero. 2011. Direct effects of type I interferons on cells of the immune system. Clin. Cancer Res. 17: 2619-2627.
54. Cousens, L. P., R. Peterson, S. Hsu, A. Dorner, J. D. Altman, R. Ahmed, and C. A. Biron. 1999. Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J. Exp. Med. 189: 1315-1328.
55. Ruby, J., and I. Ramshaw. 1991. The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma. Lymphokine Cytokine Res. 10: 353-358.
56. Atrasheuskaya, A. V., E. K. Bukin, T. M. Fredeking, and G. M. Ignatyev. 2004. Protective effect of exogenous recombinant mouse interferon-gamma and tumour necrosis factor-alpha on ectromelia virus infection in susceptible BALB/c mice. Clin. Exp. Immunol. 136: 207-214. (Pubitemid 38543437)